The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials
This study provides robust evidence supporting the use of combination therapies in HFrEF management, with newer agents offering incremental benefits when added to established guideline-directed medical therapy.
Authors
- Shao‐Hsuan Chang (ORCID: https://orcid.org/0000-0003-2545-743X)
- Jiang Bian (ORCID: https://orcid.org/0000-0002-2238-5429)
- Mustafa M. Ahmed (ORCID: https://orcid.org/0000-0003-2781-7873)
- Stephen E. Kimmel (ORCID: https://orcid.org/0000-0003-3673-2361)
- Yujia Li (ORCID: https://orcid.org/0000-0002-5655-5254)
- Ying Lü (ORCID: https://orcid.org/0000-0002-7698-8962)
- Jingchuan Guo (ORCID: https://orcid.org/0000-0001-9799-2592)
- Huilin Tang (ORCID: https://orcid.org/0000-0002-5814-6657)
- Wei‐Han Chen (ORCID: https://orcid.org/0000-0001-8545-6127)
- Wenxi Huang
- Kimberly Germinal
- Alexandra Milfort
Institutions
- Center for Drug Evaluation and Research (US)
- University of Florida (US)
- Florida College (US)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1186/s12872-024-04339-3
- Citations
- 8
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.22